Investing.com - Sotera Health (NASDAQ: SHC) reported fourth quarter EPS of $0.26, in line with the analyst estimate of $0.26. Revenue for the quarter came in at $310M versus the consensus estimate of $300.4M.
Guidance
Sotera Health sees Q1 2024 EPS of $0.65-$0.75 versus the analyst consensus of $0.87.
Sotera Health's stock price closed at $17.06. It is up 21.86% in the last 3 months and up 2.22% in the last 12 months.
Sotera Health saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Sotera Health's stock price’s past reactions to earnings here.
According to InvestingPro, Sotera Health's Financial Health score is "good performance".
Check out Sotera Health's recent earnings performance, and Sotera Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar